Copyright
©The Author(s) 2025.
World J Psychiatry. Jul 19, 2025; 15(7): 106023
Published online Jul 19, 2025. doi: 10.5498/wjp.v15.i7.106023
Published online Jul 19, 2025. doi: 10.5498/wjp.v15.i7.106023
Table 1 Baseline demographic and clinical characteristics
Characteristic | Study group (n = 60) | Control group (n = 60) | P value |
Age (year), mean ± SD | 71.3 ± 5.2 | 70.8 ± 5.5 | 0.65 |
Gender (male/female) | 34/26 | 32/28 | 0.78 |
BMI (kg/m2) | 23.5 ± 2.8 | 23.8 ± 2.6 | 0.54 |
ASA classification distribution | I: 10, II: 30, III: 20 | I: 12, II: 32, III: 16 | 0.89 |
Tumor staging | I: 10, II: 20, III: 20, IV: 10 | I: 12, II: 22, III: 18, IV: 8 | 0.92 |
Comorbidities (n) | 30 | 28 | 0.73 |
Smoking history (yes/no) | 20/40 | 18/42 | 0.81 |
Alcohol consumption (yes/no) | 15/45 | 12/48 | 0.76 |
Hypertension (yes/no) | 25/35 | 23/37 | 0.85 |
Diabetes mellitus (yes/no) | 12/48 | 10/50 | 0.79 |
Previous surgery (yes/no) | 10/50 | 8/52 | 0.71 |
Family history of cancer (yes/no) | 15/45 | 13/47 | 0.82 |
Chemotherapy history (yes/no) | 5/55 | 3/57 | 0.75 |
Radiotherapy history (yes/no) | 3/57 | 2/58 | 0.83 |
Table 2 Enhanced recovery indicators
Indicator | Study group (n = 60) | Control group (n = 60) | P value |
Time to first flatus (hours) | 48.3 ± 6.2 | 62.5 ± 7.8 | 0.002 |
Time to ambulation (hours) | 28.4 ± 4.2 | 38.6 ± 5.1 | 0.001 |
Length of hospital stay (days) | 5.2 ± 1.1 | 7.4 ± 1.3 | 0.003 |
Postoperative pain score (0-10) | 3.1 ± 1.2 | 4.5 ± 1.5 | 0.004 |
Time to first diet (hours) | 36.2 ± 5.0 | 48.7 ± 6.3 | 0.001 |
Postoperative nausea and vomiting (yes/no) | 10/50 | 20/40 | 0.012 |
Postoperative infection rate (%) | 5.0 ± 2.2 | 10.0 ± 3.1 | 0.021 |
Postoperative complications (n) | 8 | 15 | 0.034 |
Patient satisfaction score (0-10) | 8.5 ± 1.0 | 7.0 ± 1.2 | 0.001 |
Table 3 Anxiety and depression scores
Indicator | Study group (n = 60) | Control group (n = 60) | P value |
Anxiety score (mean ± SD) | 5.2 ± 1.4 | 7.8 ± 1.6 | 0.001 |
Depression score (mean ± SD) | 4.8 ± 1.2 | 7.1 ± 1.5 | 0.001 |
Patients with clinically significant anxiety (HAD score ≥ 7) (%) | 15.0% (9/60) | 35.0% (21/60) | 0.008 |
Patients with clinically significant depression (HAD score ≥ 7) (%) | 13.3% (8/60) | 31.7% (19/60) | 0.012 |
FOP score (mean ± SD) | 3.5 ± 1.0 | 5.0 ± 1.2 | 0.002 |
FAB score (mean ± SD) | 2.8 ± 0.9 | 4.2 ± 1.1 | 0.003 |
Psychological resilience score (mean ± SD) | 7.5 ± 1.5 | 5.8 ± 1.4 | 0.001 |
PostopQRS score (mean ± SD) | 85.2 ± 10.3 | 72.4 ± 12.1 | 0.001 |
Table 4 Inflammatory response analysis of inflammatory markers
Inflammatory marker | Study group (n = 60) | Control group (n = 60) | P value |
IL-6 (pg/mL) | 42.3 ± 8.5 | 68.7 ± 12.4 | < 0.001 |
TNF-α (pg/mL) | 28.4 ± 5.6 | 45.2 ± 8.9 | < 0.001 |
CRP (mg/L) | 38.5 ± 7.2 | 62.4 ± 11.3 | < 0.001 |
IL-1β (pg/mL) | 12.5 ± 3.4 | 18.7 ± 4.5 | 0.002 |
IL-10 (pg/mL) | 15.2 ± 2.8 | 10.5 ± 2.1 | 0.001 |
MCP-1 (pg/mL) | 20.3 ± 4.2 | 28.6 ± 5.8 | 0.003 |
IFN-γ (pg/mL) | 9.8 ± 2.3 | 14.5 ± 3.7 | 0.004 |
S100A8 (ng/mL) | 1.2 ± 0.3 | 2.1 ± 0.5 | 0.001 |
Table 5 Sleep quality assessment
Indicator | Study group (n = 60) | Control group (n = 60) | P value |
Global PSQI score (mean ± SD) | 5.2 ± 1.3 | 7.8 ± 1.8 | 0.002 |
Postoperative morphine equivalent consumption (mg) | 15.3 ± 3.2 | 23.6 ± 4.5 | 0.001 |
Sleep latency (minutes) | 20.4 ± 5.6 | 30.2 ± 7.1 | 0.003 |
Total sleep time (hours) | 6.8 ± 1.2 | 5.4 ± 1.0 | 0.001 |
Sleep efficiency (%) | 85.2 ± 6.3 | 72.4 ± 7.8 | 0.001 |
Sleep disturbances (n) | 12 | 24 | 0.004 |
Use of sleep medication (yes/no) | 5/55 | 15/45 | 0.012 |
Daytime dysfunction (n) | 8 | 18 | 0.015 |
ESS score (mean ± SD) | 4.5 ± 1.2 | 6.8 ± 1.5 | 0.001 |
Table 6 Multivariate analysis of postoperative anxiety and depression
Risk factor | Variable | OR (95%CI) | P value |
Postoperative anxiety (HAD-A ≥ 7) | PH + GDFT intervention | 0.38 (0.24-0.62) | 0.001 |
Age ≥ 75 years | 1.85 (1.32-2.59) | 0.003 | |
IL-6 levels at 24 hours (pg/mL) | 1.42 (1.18-1.71) | 0.002 | |
PSQI > 5 | 2.13 (1.56-2.91) | < 0.001 | |
Postoperative complications | 2.45 (1.73-3.46) | < 0.001 | |
Postoperative pain score (NRS) | 1.25 (1.05-1.48) | 0.012 | |
Duration of surgery (≥ 120 minutes) | 1.60 (1.10-2.33) | 0.015 | |
Postoperative depression (HAD-D ≥ 7) | PH + GDFT intervention | 0.41 (0.26-0.65) | 0.001 |
Age ≥ 75 years | 1.78 (1.25-2.53) | 0.002 | |
IL-6 levels at 24 hours (pg/mL) | 1.35 (1.12-1.63) | 0.003 | |
PSQI > 5 | 2.05 (1.48-2.84) | < 0.001 | |
Postoperative complications | 2.30 (1.60-3.33) | < 0.001 | |
Postoperative pain score (NRS) | 1.30 (1.08-1.56) | 0.007 | |
Duration of surgery (≥ 120 minutes) | 1.55 (1.08-2.22) | 0.018 |
- Citation: Yuan L, Zhang XM, Liu N, Shi JQ, Sun XJ, Li GL, Teng JL. Permissive hypercapnia combined with goal-directed fluid therapy improve postoperative mental health in elderly patients undergoing laparoscopic surgery. World J Psychiatry 2025; 15(7): 106023
- URL: https://www.wjgnet.com/2220-3206/full/v15/i7/106023.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i7.106023